Outlook Therapeutics (OTLK) EBT Margin (QoQ) (2015 - 2025)
Outlook Therapeutics (OTLK) EBT Margin (QoQ) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Outlook Therapeutics | 88.50 Mn | 77.26 Mn | -8,265.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.75 Mn |
| Sep 30, 2019 | 67,632.00 |
| Jun 30, 2019 | 70,411.00 |
| Mar 31, 2019 | -68,540.00 |
| Dec 31, 2018 | 73,244.00 |
| Sep 30, 2018 | -55,257.00 |
| Jun 30, 2018 | -11,557.00 |
| Mar 31, 2018 | -31,982.00 |
| Dec 31, 2017 | -45,452.00 |
| Sep 30, 2017 | 155,625.00 |
| Jun 30, 2017 | 89,550.00 |
| Mar 31, 2017 | 364,468.00 |
| Dec 31, 2016 | -416,350.00 |
| Sep 30, 2016 | 237,606.00 |
| Jun 30, 2016 | -416,048.00 |
| Mar 31, 2016 | 133,887.00 |
| Dec 31, 2015 | 195,758.00 |
| Sep 30, 2015 | -275,156.00 |
| Jun 30, 2015 | 207,600.00 |